Clinical Trial Update: Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating docetaxel with bevacizumab, with or without trastuzumab, as first-line therapy for metastatic breast cancer; the trial is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-08-23